Ralliant Corporation (NYSE:RAL) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Ralliant Corporation (NYSE:RAL) have earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $57.8889.

RAL has been the topic of several research analyst reports. Truist Financial assumed coverage on Ralliant in a report on Friday, December 12th. They set a “buy” rating and a $62.00 target price on the stock. Oppenheimer upped their price target on shares of Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a research report on Monday, December 15th. Royal Bank Of Canada raised their price objective on shares of Ralliant from $45.00 to $52.00 and gave the company a “sector perform” rating in a research report on Friday, November 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Ralliant in a research note on Monday, December 29th. Finally, Citigroup raised shares of Ralliant from a “neutral” rating to a “buy” rating and increased their price target for the company from $53.00 to $61.00 in a research note on Monday, December 8th.

Institutional Investors Weigh In On Ralliant

A number of institutional investors and hedge funds have recently made changes to their positions in RAL. Dodge & Cox bought a new position in Ralliant in the second quarter valued at about $523,571,000. Viking Global Investors LP bought a new position in shares of Ralliant in the 2nd quarter valued at about $257,200,000. State Street Corp acquired a new stake in shares of Ralliant during the 2nd quarter worth approximately $213,096,000. Flossbach Von Storch SE acquired a new stake in shares of Ralliant during the 2nd quarter worth approximately $198,077,000. Finally, Norges Bank bought a new stake in shares of Ralliant during the second quarter worth approximately $108,453,000.

Ralliant Trading Up 0.9%

NYSE:RAL opened at $51.67 on Tuesday. The company has a market capitalization of $5.83 billion and a PE ratio of 40.69. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39. Ralliant has a 1 year low of $40.70 and a 1 year high of $55.08. The firm has a 50 day moving average price of $48.64.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.02. The business had revenue of $529.10 million for the quarter, compared to analyst estimates of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Monday, December 8th were given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Monday, December 8th. Ralliant’s dividend payout ratio (DPR) is presently 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.